Day: February 1, 2025

BEIJING, China, Feb. 01, 2025 (GLOBE NEWSWIRE) — Li Auto Inc. (“Li Auto” or the “Company”) (Nasdaq: LI; HKEX: 2015), a leader in China’s new energy vehicle market, today announced that it delivered 29,927 vehicles in January 2025. As of January 31, 2025, Li Auto’s cumulative deliveries reached 1,163,799. Li L6 surpassed the 200,000 cumulative delivery milestone in January 2025. Li Auto sustained its leadership as the sales champion of Chinese automotive brand in the passenger vehicle market priced at RMB200,000 and above, with Li L6 maintaining its position as the best-selling extended-range electric vehicle model in China for seven consecutive months. In January, the Company released OTA update version 7.0, introducing the new Li AD Max V13.0, to provide users with enhanced autonomous driving experience. As of January 31, 2025,...

NOT FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES VANCOUVER, BC, Jan. 31, 2025 (GLOBE NEWSWIRE) — Eat & Beyond Global Holdings Inc. (CSE: EATS) (OTCPK: EATBF) (FSE: 988) (“Eat & Beyond” or the “Company”), an investment issuer focused on the global plant-based and alternative protein sector, is pleased to announce that the Company has entered into a securities exchange agreement dated January 31, 2025 (the “Definitive Agreement”), which sets out the terms and conditions for the acquisition by the Company of 100% of the issued and outstanding shares and 100% of the outstanding warrants in the capital of Milo Media Technologies Inc. (“Milo Media”) in exchange for securities of Eat & Beyond (the “Transaction”). Pursuant to the terms of the Definitive Agreement, the material terms...

VANCOUVER, B.C., Jan. 31, 2025 (GLOBE NEWSWIRE) — Yerbaé Brands Corp. (TSX-V: YERB.U; OTCQX: YERBF) (“Yerbaé” or the “Company”), a plant-based energy beverage company, is pleased to announce that it has secured a US$1,000,000 loan pursuant to the terms of a loan agreement (the “Loan Agreement”) dated January 29, 2025 with Maximcash Solutions LLC (“Maximcash”). Pursuant to the terms of the Loan Agreement, Maximcash agreed to loan US$1,000,000 (the “Loan”) to the Company for a period of twelve (12) months (the “Maturity”), payable in twenty four (26) bi-weekly payments with an average monthly cost of approximately US$103,333. The Loan, which was approved by consent resolution of directors of the Company, is subject to an interest rate of 43.26% calculated annually and secured against all present and after-acquired property of its...

MALVERN, Pa., Jan. 31, 2025 (GLOBE NEWSWIRE) — via IBN – Annovis Bio, Inc. (NYSE: ANVS) (“Annovis” or the “Company”), a late-stage clinical drug platform company pioneering transformative therapies for neurodegenerative diseases such as Alzheimer’s disease (AD) and Parkinson’s disease (PD), today announced that it intends to offer to sell common stock and warrants in an underwritten public offering. All of the common stock and warrants are to be sold by the Company. ThinkEquity is acting as sole book-running manager for the offering. The Company expects to grant the underwriter a 45-day option to purchase up to an additional 15% of the number of shares of common stock and/or warrants sold in this offering to cover over-allotments, if any.The offering is subject to market conditions and there can be no assurance as to whether or...